about
PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In VivoAdjuvants for peptide-based cancer vaccinesTLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin RepairAdjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityA Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed GlioblastomaVaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.Strategies for designing synthetic immune agonists.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines.Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.TLR Agonists as Adjuvants for Cancer Vaccines.Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.Antiviral Defense and Innate Immune Memory in the Oyster.Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
P2860
Q27324710-B75941D6-5687-401E-AECE-0F76F2885170Q28072236-41B5752B-922F-4777-B2BC-8B42E742D710Q35972372-CF120A77-664A-489A-8233-6252C7E69FBBQ36538834-6234A17D-96E4-4DB2-B4DC-225FEF85B1F1Q37262109-CE03CD4D-9158-42BC-BBC5-21AD49F42818Q37741161-450BFF3E-B280-4293-8FFA-CE9ED21B7F2DQ38841677-064FD581-1ACE-4794-A169-7AFD9E7B5224Q39450802-A0DC1A3A-D756-4007-99E3-C4200357ABBEQ40248942-EB94E690-C899-44AE-9606-91F991D5FCAAQ40256165-A85BA954-714E-4B9F-A967-721865BB0BC9Q40284594-873E30E5-C108-4F60-AB8E-16CE577B6645Q41997055-645AB410-C575-4B22-B232-073123BA1118Q47120596-7942291F-41F7-4F90-837C-4C439FB00B98Q52353019-751B311F-8FBE-4353-ABE8-02836234E61EQ57462243-0AC72384-0616-4A52-A347-65C5D932CEBB
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Vaccine adjuvant uses of poly-IC and derivatives.
@en
type
label
Vaccine adjuvant uses of poly-IC and derivatives.
@en
prefLabel
Vaccine adjuvant uses of poly-IC and derivatives.
@en
P2860
P1476
Vaccine adjuvant uses of poly-IC and derivatives.
@en
P2093
Andres M Salazar
Karen A O Martins
P2860
P304
P356
10.1586/14760584.2015.966085
P50
P577
2014-10-13T00:00:00Z